Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Ca...(6) (124) (18) (427) Loss ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial
Date:11/5/2007
6) (124) (18) (427)
Loss from continuing operations (6,100) (3,558) (16,681) (12,025)
Loss from discontinued operations - - - (88)
Net loss $(6,100) $(3,558) $(16,681) $(12,113)
Basic and diluted loss per share
from continuing operations $(0.37) $(0.22) $(1.01) $(1.02)
Basic and diluted loss per share
from discontinued operations $- $- $- $(0.01)
Basic and diluted loss per share $(0.37) $(0.22) $(1.01) $(1.03)
Basic and diluted weighted average
shares outstanding 16,600 16,342 16,495 11,763
'/>"/>
| SOURCE Tapestry Pharmaceuticals, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Tapestry to Host Conference Call on November 5th to Discuss Third Quarter 2007 Financial Results
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
Breaking Biology Technology:YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3
[0] YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT[0] Lotus Pharmaceuticals, Inc. Appoints OTC Division Head[0] YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES[0] Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner
Other Biology Technology:Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation 2Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation 3ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis 2ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis 3
Breaking Biology News(10 mins):Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5New discoveries could improve climate projections 2Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 1Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 2Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 3JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 1JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 2JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 3Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 1Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 2Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 3
Other Biology News:Researchers develop new ultrasensitive assay to detect most poisonous substance known 2Early treatment of stomach infection may prevent cancer 2Early treatment of stomach infection may prevent cancer 3US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 2US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 3US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |